<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-239-7-147-161</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-3233</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Влияние различных видов аутопробиотиков на микробиоту и поведение при коррекции экспериментального дисбиоза кишечника</article-title><trans-title-group xml:lang="en"><trans-title>The effect of various types of autoprobiotics on the microbiota and behavior in correction of experimental intestinal dysbiosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2569-6660</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермоленко</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermolenko</surname><given-names>E. I.</given-names></name></name-alternatives><email xlink:type="simple">lermolenko1@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0030-9548</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>N. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1073-6508</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котылева</surname><given-names>М. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotyleva</surname><given-names>M. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мацулевич</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Matsulevich</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9570-4769</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карасева</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Karaseva</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-2618-7670</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Забельникова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zabelnikova</surname><given-names>A. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1010-6768</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдурасулова</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdurasulova</surname><given-names>I. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное научное учреждение «Институт Экспериментальной Медицины»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Experimental Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>01</month><year>2026</year></pub-date><volume>0</volume><issue>7</issue><fpage>147</fpage><lpage>161</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ермоленко Е.И., Новикова Н.С., Котылева М.П., Мацулевич А.В., Карасева А.Б., Забельникова А.М., Абдурасулова И.Н., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ермоленко Е.И., Новикова Н.С., Котылева М.П., Мацулевич А.В., Карасева А.Б., Забельникова А.М., Абдурасулова И.Н.</copyright-holder><copyright-holder xml:lang="en">Ermolenko E.I., Novikova N.S., Kotyleva M.P., Matsulevich A.V., Karaseva A.B., Zabelnikova A.M., Abdurasulova I.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/3233">https://www.nogr.org/jour/article/view/3233</self-uri><abstract><p>Изучено влияние аутопробиотиков, индигенных непатогенных энтерококков и полученного путем культивирования фекальных проб индигенного консорциума микробов (ИКМ), на восстановление кишечного микробиоценоза и поведенческие реакции у самцов крыс Вистар с дисбиозом кишечника, индуцированным введением ампициллина и метронидазола. Использованные условия культивирования фекальных проб приводили к увеличению в ИКМ доли лактобацилл и энтерококков. При анализе состояния животных, в частности при оценке двигательной и ориентировочно-исследовательской активности в тесте «Открытое поле», а также результатов секвенирования фрагмента гена, кодирующего 16S рРНК после введения аутопробиотиков выявлены: более быстрое исчезновение диспепсии, снижение признаков тревожности и компенсаторные изменения состава микробиоты. Состав микробиома кишечника имел существенные различия в группах животных в зависимости от воздействия после введения антимикробных препаратов. Причем в группе, не получавшей аутопробиотики, наряду с более выраженными признаками дисбиоза были выявлены признаки спонтанного восстановления микробиоты. Максимальные изменения микробиоты кишечника и влияние на поведение животных оказывал ИКМ. Выявленные феномены следует принимать во внимание при разработке методов комплексной терапии заболеваний, сопровождающихся развитием дисбиотических состояний, особенно с выраженными изменениями в функционировании ЦНС.</p></abstract><trans-abstract xml:lang="en"><p>The effect of autoprobiotics, indigenous nonpathogenic enterococci, and the indigenous consortium of microbes (ICM) obtained from fecal samples on the restoration of intestinal microbiocenosis and behavioral responses in male Wistar rats with intestinal dysbiosis induced by ampicillin and metronidazole was studied. The conditions used for fecal sample cultivation led to an increase in the proportion of lactobacilli and enterococci in the ICM. When analyzing the condition of animals, in particular, when evaluating motor and exploratory activity in the “open field” test, as well as the results of 16S rRNA sequencing after administration of autoprobiotics, the following were revealed: faster disappearance of dyspepsia, decreased signs of anxiety, and compensatory changes in the composition of the microbiota. The composition of the intestinal microbiome had significant differences in the animal groups depending on exposure after administration of antimicrobial drugs. Moreover, in the group that did not receive autoprobiotics, along with more pronounced signs of dysbiosis, signs of self-healing were revealed. The maximum changes in the intestinal microbiota and the effect on animal behavior were exerted by ICM. The revealed phenomena should be taken into account when developing methods of complex therapy of diseases accompanied by the development of dysbiotic conditions, especially with pronounced changes in the functioning of the central nervous system.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микробный консорциум</kwd><kwd>энтерококки</kwd><kwd>микробиом</kwd><kwd>ориентировочно-исследовательской активность</kwd><kwd>корреляционный анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>microbial consortium</kwd><kwd>enterococci</kwd><kwd>microbiome</kwd><kwd>tentative research activity</kwd><kwd>correlation analysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lyte M. The microbial organ in the gut as a driver of homeostasis and disease. Medical hypotheses. 2010;74(4):634-638. doi: 10.1016/j.mehy.2009.10.025.</mixed-citation><mixed-citation xml:lang="en">Lyte M. The microbial organ in the gut as a driver of homeostasis and disease. Medical hypotheses. 2010;74(4):634-638. doi: 10.1016/j.mehy.2009.10.025.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Averina O.V., Danilenko V.N. Human intestinal microbiota: role in the formation and functioning of the nervous system. Microbiology. 2017;86(1):5-24. (In Russ.) doi: 10.7868/S0026365617010050.@@ Аверина О.В., Даниленко В.Н. Микробиота кишечника человека: роль в становлении и функционировании нервной системы. Микробиология. 2017;86(1):5-24. doi: 10.7868/S0026365617010050.</mixed-citation><mixed-citation xml:lang="en">Averina O.V., Danilenko V.N. Human intestinal microbiota: role in the formation and functioning of the nervous system. Microbiology. 2017;86(1):5-24. (In Russ.) doi: 10.7868/S0026365617010050.@@ Аверина О.В., Даниленко В.Н. Микробиота кишечника человека: роль в становлении и функционировании нервной системы. Микробиология. 2017;86(1):5-24. doi: 10.7868/S0026365617010050.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kovtun A.S., Averina O.V., Zakharevich N.V., Kasyanov A.S., Danilenko V.N. In silico determination of a metagenomic signature reflecting the neurometabolic potential of the human intestinal microbiota in norm. Genetics. 2018;54(9):1081-1091. (in Russ.)@@ Ковтун А.С., Аверина О.В., Захаревич Н.В., Касьянов А.С., Даниленко В.Н. In silico определение метагеномной сигнатуры, отражающей нейрометаболический потенциал микробиоты кишечника человека в норме. Генетика. 2018;54(9):1081-1091.</mixed-citation><mixed-citation xml:lang="en">Kovtun A.S., Averina O.V., Zakharevich N.V., Kasyanov A.S., Danilenko V.N. In silico determination of a metagenomic signature reflecting the neurometabolic potential of the human intestinal microbiota in norm. Genetics. 2018;54(9):1081-1091. (in Russ.)@@ Ковтун А.С., Аверина О.В., Захаревич Н.В., Касьянов А.С., Даниленко В.Н. In silico определение метагеномной сигнатуры, отражающей нейрометаболический потенциал микробиоты кишечника человека в норме. Генетика. 2018;54(9):1081-1091.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences. 2011;108(38):16050-16055. doi: 10.1073/pnas.1102999108.</mixed-citation><mixed-citation xml:lang="en">Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., Bienenstock J., Cryan J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences. 2011;108(38):16050-16055. doi: 10.1073/pnas.1102999108.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Collins S.M., Michael S., Premysl B. The interplay between the intestinal microbiota and the brain. Nature Reviews Microbiology. 2012;10(11):735-742. doi: 10.1038/nrmicro2876.</mixed-citation><mixed-citation xml:lang="en">Collins S.M., Michael S., Premysl B. The interplay between the intestinal microbiota and the brain. Nature Reviews Microbiology. 2012;10(11):735-742. doi: 10.1038/nrmicro2876.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Messaoudi M., Nicolas V., Jean-François B., Desor D., Javelot H., Rougeot C. Beneficial Psychological Effects of a Probiotic Formulation (Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175) in Healthy Human Volunteers. Gut Microbes. 2011;2(4):256-261. doi: 10.4161/gmic.2.4.16108.</mixed-citation><mixed-citation xml:lang="en">Messaoudi M., Nicolas V., Jean-François B., Desor D., Javelot H., Rougeot C. Beneficial Psychological Effects of a Probiotic Formulation (Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175) in Healthy Human Volunteers. Gut Microbes. 2011;2(4):256-261. doi: 10.4161/gmic.2.4.16108.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tillisch K., Labus J., Kilpatrick L. et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013;144(7):1394-1401. doi: 10.1053/j.gastro.2013.02.043.</mixed-citation><mixed-citation xml:lang="en">Tillisch K., Labus J., Kilpatrick L. et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013;144(7):1394-1401. doi: 10.1053/j.gastro.2013.02.043.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Andreeva I.V., Tolpygo A.V., Andreev, V.A. et al. Psychobiotics: a new way in psychopharmacology, or How do bacteria manage our brain? Clinical microbiology and antimicrobial chemotherapy. 2022;24(2):108-133. (In Russ.) doi: 10.36488/cmac.2022.2.108-133.@@ Андреева И.В., Толпыго А.В., Андреев В.А., Азизов И.С., Гольман И.А., Осипова Н.Н., Привольнев В.В., Стецюк О.У., Соколовская В.В. Психобиотики: новое направление в психофармакологии, или как бактерии влияют на наш мозг? Клиническая микробиология и антимикробная химиотерапия. 2022;24(2):108-133. doi: 10.36488/cmac.2022.2.108-133.</mixed-citation><mixed-citation xml:lang="en">Andreeva I.V., Tolpygo A.V., Andreev, V.A. et al. Psychobiotics: a new way in psychopharmacology, or How do bacteria manage our brain? Clinical microbiology and antimicrobial chemotherapy. 2022;24(2):108-133. (In Russ.) doi: 10.36488/cmac.2022.2.108-133.@@ Андреева И.В., Толпыго А.В., Андреев В.А., Азизов И.С., Гольман И.А., Осипова Н.Н., Привольнев В.В., Стецюк О.У., Соколовская В.В. Психобиотики: новое направление в психофармакологии, или как бактерии влияют на наш мозг? Клиническая микробиология и антимикробная химиотерапия. 2022;24(2):108-133. doi: 10.36488/cmac.2022.2.108-133.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu W.H., Chuang H.L., Huang Y.T., Wu C.C., Chou G.T., Wang S., Tsai Y.C. Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice. Behavioural brain research. 2016;298:202-209.</mixed-citation><mixed-citation xml:lang="en">Liu W.H., Chuang H.L., Huang Y.T., Wu C.C., Chou G.T., Wang S., Tsai Y.C. Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice. Behavioural brain research. 2016;298:202-209.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang H., Ling Z., Zhang Y. Mao H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain, behavior, and immunity. 2015;48:186-194. doi: 1016/j.bbi.2015.03.016.</mixed-citation><mixed-citation xml:lang="en">Jiang H., Ling Z., Zhang Y. Mao H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain, behavior, and immunity. 2015;48:186-194. doi: 1016/j.bbi.2015.03.016.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Messaoudi M., Lalonde R., Violle N. et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition. 2011;105:755-764.</mixed-citation><mixed-citation xml:lang="en">Messaoudi M., Lalonde R., Violle N. et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition. 2011;105:755-764.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Abdurasulova I.N., Sofonova A.F., Sizov V.V., Kotyleva M.P., Ermolenko E.I. Effect of various probiotics on motor and exploratory activity of rats. Health is the basis of human potential: problems and solutions. Proceedings of the X All-Russian scientific and practical conference with international participation. 2015;10(1):1047-1051. (In Russ.)@@ Абдурасулова И.Н., Софонова А.Ф., Сизов В.В., Котылева М.П., Ермоленко Е.И. Действие различных пробиотиков на двигательную и ориентировочно-исследовательскую активность крыс. Здоровье - основа человеческого потенциала: проблемы и пути их решения. Труды X Всероссийской научно-практической конференции с международным участием. 2015;10(1):1047-1051.</mixed-citation><mixed-citation xml:lang="en">Abdurasulova I.N., Sofonova A.F., Sizov V.V., Kotyleva M.P., Ermolenko E.I. Effect of various probiotics on motor and exploratory activity of rats. Health is the basis of human potential: problems and solutions. Proceedings of the X All-Russian scientific and practical conference with international participation. 2015;10(1):1047-1051. (In Russ.)@@ Абдурасулова И.Н., Софонова А.Ф., Сизов В.В., Котылева М.П., Ермоленко Е.И. Действие различных пробиотиков на двигательную и ориентировочно-исследовательскую активность крыс. Здоровье - основа человеческого потенциала: проблемы и пути их решения. Труды X Всероссийской научно-практической конференции с международным участием. 2015;10(1):1047-1051.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Steenbergen L., Sellaro R., van Hemert S. et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, behavior, and immunity. 2015;48:258-264. doi:10.1016/j.bbi.2015.04.003.</mixed-citation><mixed-citation xml:lang="en">Steenbergen L., Sellaro R., van Hemert S. et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, behavior, and immunity. 2015;48:258-264. doi:10.1016/j.bbi.2015.04.003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ermolenko E., Sitkin S., Vakhitov T. et al. Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome. Beneficial Microbes. 2023;14(2):119-130. doi: 10.3920/BM2022.0053.</mixed-citation><mixed-citation xml:lang="en">Ermolenko E., Sitkin S., Vakhitov T. et al. Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome. Beneficial Microbes. 2023;14(2):119-130. doi: 10.3920/BM2022.0053.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bakulina N.V., Tikhonov S.V., Ermolenko E.I. et al. The use of E. faecium probiotic and autoprobiotic in patients with type 2 diabetes mellitus. HERALD of North-Western State Medical University named after II Mechnikov. 2022;14(1):77-88. (In Russ.) doi: 10.17816/mechnikov104795.@@ Бакулина Н.В., Тихонов С.В., Ермоленко Е.И., Котылева М.П., Лаврёнова Н.С., Топалова Ю.Г., Симаненков В.И., Суворов А.Н. Использование пробиотических и аутопробиотических Enterococcus faecium в лечении пациентов с сахарным диабетом 2-го типа. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2022;14(1):77-88. doi: 10.17816/mechnikov104795.</mixed-citation><mixed-citation xml:lang="en">Bakulina N.V., Tikhonov S.V., Ermolenko E.I. et al. The use of E. faecium probiotic and autoprobiotic in patients with type 2 diabetes mellitus. HERALD of North-Western State Medical University named after II Mechnikov. 2022;14(1):77-88. (In Russ.) doi: 10.17816/mechnikov104795.@@ Бакулина Н.В., Тихонов С.В., Ермоленко Е.И., Котылева М.П., Лаврёнова Н.С., Топалова Ю.Г., Симаненков В.И., Суворов А.Н. Использование пробиотических и аутопробиотических Enterococcus faecium в лечении пациентов с сахарным диабетом 2-го типа. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2022;14(1):77-88. doi: 10.17816/mechnikov104795.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ilyin V.K., Suvorov A.N., Kiryukhina N.V. et al. Autoprobiotics as a means of preventing infectious and inflammatory diseases in humans in an artificial habitat. Bulletin of the Russian Academy of Medical Sciences, 2013; 68(2): 56-62. (In Russ.)@@ Ильин В.К., Суворов А.Н., Кирюхина Н.В., Усанова Н.А., Старкова Л.В., Бояринцев В.В., Карасева А.Б. Аутопробиотики как средство профилактики инфекционновоспалительных заболеваний у человека в искусственной среде обитания. Вестник Российской академии медицинских наук. 2013;68(2):56-62.</mixed-citation><mixed-citation xml:lang="en">Ilyin V.K., Suvorov A.N., Kiryukhina N.V. et al. Autoprobiotics as a means of preventing infectious and inflammatory diseases in humans in an artificial habitat. Bulletin of the Russian Academy of Medical Sciences, 2013; 68(2): 56-62. (In Russ.)@@ Ильин В.К., Суворов А.Н., Кирюхина Н.В., Усанова Н.А., Старкова Л.В., Бояринцев В.В., Карасева А.Б. Аутопробиотики как средство профилактики инфекционновоспалительных заболеваний у человека в искусственной среде обитания. Вестник Российской академии медицинских наук. 2013;68(2):56-62.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Suvorov A., Karaseva A., Kotyleva M. et al. Autoprobiotics as an approach for restoration of personalised microbiota. Frontiers in microbiology. 2018;9:1869. doi: 10.3389/fmicb.2018.01869.</mixed-citation><mixed-citation xml:lang="en">Suvorov A., Karaseva A., Kotyleva M. et al. Autoprobiotics as an approach for restoration of personalised microbiota. Frontiers in microbiology. 2018;9:1869. doi: 10.3389/fmicb.2018.01869.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ermolenko E.I., Donetsk V.N., Dmitrieva Yu.V., et al. Effect of probiotic enterococci on functional characteristics of the rat intestine in dysbiosis induced by antibiotics. Bulletin of St. Petersburg University. Medicine. 2009;1:157-167. (In Russ.)@@ Ермоленко Е.И., Донец В.Н., Дмитриева Ю.В. и др. Влияние пробиотических энтерококков на функциональные характеристики кишечника крыс при дисбиозе, индуцированном антибиотиками. Вестник Санкт-Петербургского университета. Медицина. 2009;1:157-167.</mixed-citation><mixed-citation xml:lang="en">Ermolenko E.I., Donetsk V.N., Dmitrieva Yu.V., et al. Effect of probiotic enterococci on functional characteristics of the rat intestine in dysbiosis induced by antibiotics. Bulletin of St. Petersburg University. Medicine. 2009;1:157-167. (In Russ.)@@ Ермоленко Е.И., Донец В.Н., Дмитриева Ю.В. и др. Влияние пробиотических энтерококков на функциональные характеристики кишечника крыс при дисбиозе, индуцированном антибиотиками. Вестник Санкт-Петербургского университета. Медицина. 2009;1:157-167.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ermolenko E.I., Abdurasulova I.N., Kotyleva M.P. et al. Effects of indigenous enterococci on the intestinal microbiota and the behavior of rats on correction of experimental dysbiosis. Neuroscience and Behavioral Physiology. 2018;48(4):496-505. doi: 1007/s11055-018-0591-7.</mixed-citation><mixed-citation xml:lang="en">Ermolenko E.I., Abdurasulova I.N., Kotyleva M.P. et al. Effects of indigenous enterococci on the intestinal microbiota and the behavior of rats on correction of experimental dysbiosis. Neuroscience and Behavioral Physiology. 2018;48(4):496-505. doi: 1007/s11055-018-0591-7.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Suvorov A.N., Simanenkov V.I., Sundukova Z.R. et al. Method for producing autoprobiotic of Enterocuccus faecium being representative of indigenic host intestinal microflora. Patent on the application. No 2460778С1, 30.12.2010. (In Russ.)@@ Суворов А.Н., Симаненков В.И., Сундукова З.Р. и др. Способ получения аутопробиотика на основе Enterocuccus faecium, представителя индигенной микрофлоры кишечника хозяина. Патент по заявке No 2460778С1 от 30.12.2010 г.</mixed-citation><mixed-citation xml:lang="en">Suvorov A.N., Simanenkov V.I., Sundukova Z.R. et al. Method for producing autoprobiotic of Enterocuccus faecium being representative of indigenic host intestinal microflora. Patent on the application. No 2460778С1, 30.12.2010. (In Russ.)@@ Суворов А.Н., Симаненков В.И., Сундукова З.Р. и др. Способ получения аутопробиотика на основе Enterocuccus faecium, представителя индигенной микрофлоры кишечника хозяина. Патент по заявке No 2460778С1 от 30.12.2010 г.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Suvorov A.N., Ermolenko E.I., Kotyleva M.P., Tsapieva A.N. Method for preparing an autoprobiotic based on an anaerobic consortium of bacteria. Patent for invention RU 2734896 C2, 10/26/2020. Application No. 2018147697 dated 12/28/2018. (In Russ.)@@ Суворов А.Н., Ермоленко Е.И., Котылева М.П., Цапиева А.Н. Способ приготовления аутопробиотика на основе анаэробного консорциума бактерий. Патент на изобретение RU 2734896 C2, 26.10.2020. Заявка № 2018147697 от 28.12.2018.</mixed-citation><mixed-citation xml:lang="en">Suvorov A.N., Ermolenko E.I., Kotyleva M.P., Tsapieva A.N. Method for preparing an autoprobiotic based on an anaerobic consortium of bacteria. Patent for invention RU 2734896 C2, 10/26/2020. Application No. 2018147697 dated 12/28/2018. (In Russ.)@@ Суворов А.Н., Ермоленко Е.И., Котылева М.П., Цапиева А.Н. Способ приготовления аутопробиотика на основе анаэробного консорциума бактерий. Патент на изобретение RU 2734896 C2, 26.10.2020. Заявка № 2018147697 от 28.12.2018.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ermolenko E., Gromova L., Borschev Y. et al. Influence of different probiotic lactic acid bacteria on microbiota and metabolism of rats with dysbiosis. Bioscience of microbiota, food and health. 2013; 32(2): 41-49. doi: 10.12938/bmfh.32.41.</mixed-citation><mixed-citation xml:lang="en">Ermolenko E., Gromova L., Borschev Y. et al. Influence of different probiotic lactic acid bacteria on microbiota and metabolism of rats with dysbiosis. Bioscience of microbiota, food and health. 2013; 32(2): 41-49. doi: 10.12938/bmfh.32.41.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ermolenko E., Rybalchenko O., Borshev Y. et al. Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis. Beneficial microbes. 2018; 9(6): 937-950. doi: 10.3920/BM2017.0117.</mixed-citation><mixed-citation xml:lang="en">Ermolenko E., Rybalchenko O., Borshev Y. et al. Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis. Beneficial microbes. 2018; 9(6): 937-950. doi: 10.3920/BM2017.0117.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156(11):3216-3223. doi: 10.1099/mic.0.040618-0.</mixed-citation><mixed-citation xml:lang="en">Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156(11):3216-3223. doi: 10.1099/mic.0.040618-0.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C., Feng S., Huo F., Liu H. Effects of four antibiotics on the diversity of the intestinal microbiota. Microbiology spectrum. 2022;10: e01904-21. doi: 10.1128/spectrum.01904-21.</mixed-citation><mixed-citation xml:lang="en">Huang C., Feng S., Huo F., Liu H. Effects of four antibiotics on the diversity of the intestinal microbiota. Microbiology spectrum. 2022;10: e01904-21. doi: 10.1128/spectrum.01904-21.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">McFarland L.V. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ open. 2014;4(8):1-17. doi: 10.1136/bmjopen-2014-005047.</mixed-citation><mixed-citation xml:lang="en">McFarland L.V. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ open. 2014;4(8):1-17. doi: 10.1136/bmjopen-2014-005047.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ermolenko E.I., Erofeev N.P., Zakharova L.B., et al. Features of the composition of the intestinal microbiota and motility after correction of experimental dysbiosis with probiotic and autoprobiotic enterococci. Experimental and Clinical Gastroenterology. 2017;7(143):89-96. (In Russ.)@@ Ермоленко Е.И., Ерофеев Н.П., Захарова Л.Б. и др. Особенности состава микробиоты и моторики кишечника после коррекции экспериментального дисбиоза пробиотическими и аутопробиотическими энтерококками. Экспериментальная и клиническая гастроэнтерология. 2017;7(143):89-96.</mixed-citation><mixed-citation xml:lang="en">Ermolenko E.I., Erofeev N.P., Zakharova L.B., et al. Features of the composition of the intestinal microbiota and motility after correction of experimental dysbiosis with probiotic and autoprobiotic enterococci. Experimental and Clinical Gastroenterology. 2017;7(143):89-96. (In Russ.)@@ Ермоленко Е.И., Ерофеев Н.П., Захарова Л.Б. и др. Особенности состава микробиоты и моторики кишечника после коррекции экспериментального дисбиоза пробиотическими и аутопробиотическими энтерококками. Экспериментальная и клиническая гастроэнтерология. 2017;7(143):89-96.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Volkova GS, Serba EM. New Multistrain Bacterial Consortium for Feed Probiotics. Food Processing: Techniques and Technology. 2021;51(2):260-269. (In Russ.) doi: 10.21603/2074-9414-2021-2-260-269.@@ Волкова Г.С., Серба Е.М. Создание многоштаммового бактериального консорциума для технологии пробиотических препаратов кормового назначения. Техника и технология пищевых производств. 2021;51(2): 260-269. doi: 10.21603/2074-9414-2021-2-260-269.</mixed-citation><mixed-citation xml:lang="en">Volkova GS, Serba EM. New Multistrain Bacterial Consortium for Feed Probiotics. Food Processing: Techniques and Technology. 2021;51(2):260-269. (In Russ.) doi: 10.21603/2074-9414-2021-2-260-269.@@ Волкова Г.С., Серба Е.М. Создание многоштаммового бактериального консорциума для технологии пробиотических препаратов кормового назначения. Техника и технология пищевых производств. 2021;51(2): 260-269. doi: 10.21603/2074-9414-2021-2-260-269.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kattel A., Aro V., Lahtvee P.J., Kazantseva J., Jõers A., Nahku R., Belouah. I. Exploring the resilience and stability of a defined human gut microbiota consortium: An isothermal microcalorimetric study. Microbiologyopen. 2024 Aug;13(4): e1430. doi: 10.1002/mbo3.1430.</mixed-citation><mixed-citation xml:lang="en">Kattel A., Aro V., Lahtvee P.J., Kazantseva J., Jõers A., Nahku R., Belouah. I. Exploring the resilience and stability of a defined human gut microbiota consortium: An isothermal microcalorimetric study. Microbiologyopen. 2024 Aug;13(4): e1430. doi: 10.1002/mbo3.1430.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Precup G., Vodnar D.C. Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. British Journal of Nutrition. 2019; 122(2):131-140. doi: 10.1017/S0007114519000680.</mixed-citation><mixed-citation xml:lang="en">Precup G., Vodnar D.C. Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. British Journal of Nutrition. 2019; 122(2):131-140. doi: 10.1017/S0007114519000680.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chang D., Sharma L., Dela Cruz, C.S., Zhang D. Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Frontiers in microbiology. 2021;12: 750662. doi: 10.3389/fmicb.2021.750662.</mixed-citation><mixed-citation xml:lang="en">Chang D., Sharma L., Dela Cruz, C.S., Zhang D. Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Frontiers in microbiology. 2021;12: 750662. doi: 10.3389/fmicb.2021.750662.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Arato V., Raso M.M., Gasperini G., Berlanda Scorza F., Micoli F. Prophylaxis and treatment against Klebsiella pneumoniae: current insights on this emerging anti-microbial resistant global threat.International journal of molecular sciences. 2021;22(8):4042. doi: 10.3390/ijms22084042.</mixed-citation><mixed-citation xml:lang="en">Arato V., Raso M.M., Gasperini G., Berlanda Scorza F., Micoli F. Prophylaxis and treatment against Klebsiella pneumoniae: current insights on this emerging anti-microbial resistant global threat.International journal of molecular sciences. 2021;22(8):4042. doi: 10.3390/ijms22084042.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Russo A., Fusco P., Morrone H.L., Trecarichi E.M., Torti C. New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Review of Anti-infective Therapy. 2023;21(1):41-55. doi: 10.1080/14787210.2023.2151435.</mixed-citation><mixed-citation xml:lang="en">Russo A., Fusco P., Morrone H.L., Trecarichi E.M., Torti C. New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Review of Anti-infective Therapy. 2023;21(1):41-55. doi: 10.1080/14787210.2023.2151435.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hiippala K., Kainulainen V., Kalliomäki M., Arkkila P., Satokari R. Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Frontiers in microbiology. 2016;7:1706. doi: 10.3389/fmicb.2016.01706.</mixed-citation><mixed-citation xml:lang="en">Hiippala K., Kainulainen V., Kalliomäki M., Arkkila P., Satokari R. Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Frontiers in microbiology. 2016;7:1706. doi: 10.3389/fmicb.2016.01706.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sorouri B., Rodriguez C.I., Gaut B.S., Allison S.D. Variation in Sphingomonas traits across habitats and phylogenetic clades. Frontiers in Microbiology. 2023;14:1146165. doi: 10.3389/fmicb.2023.1146165.</mixed-citation><mixed-citation xml:lang="en">Sorouri B., Rodriguez C.I., Gaut B.S., Allison S.D. Variation in Sphingomonas traits across habitats and phylogenetic clades. Frontiers in Microbiology. 2023;14:1146165. doi: 10.3389/fmicb.2023.1146165.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Doughari H.J., Ndakidemi P.A., Human I.S., Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes and environments. 2011;26(2): 101-112. doi:10.1264/jsme2.me10179.</mixed-citation><mixed-citation xml:lang="en">Doughari H.J., Ndakidemi P.A., Human I.S., Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes and environments. 2011;26(2): 101-112. doi:10.1264/jsme2.me10179.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Gorvitovskaia A., Holmes S.P., Huse S.M.Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome. 2016;4(1):15. doi: 10.1186/s40168-016-0160-7.</mixed-citation><mixed-citation xml:lang="en">Gorvitovskaia A., Holmes S.P., Huse S.M.Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome. 2016;4(1):15. doi: 10.1186/s40168-016-0160-7.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Boyanova L. Cutibacterium acnes (formerly Propionibacterium acnes): friend or foe? Future Microbiology. 2023;18(4): 235-244. doi: 10.2217/fmb-2022-0191.</mixed-citation><mixed-citation xml:lang="en">Boyanova L. Cutibacterium acnes (formerly Propionibacterium acnes): friend or foe? Future Microbiology. 2023;18(4): 235-244. doi: 10.2217/fmb-2022-0191.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Davari S., Talaei S.A., Alaei H., Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience. 2013;240:287-296. doi: 10.1016/j.neuroscience.2013.02.055.</mixed-citation><mixed-citation xml:lang="en">Davari S., Talaei S.A., Alaei H., Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience. 2013;240:287-296. doi: 10.1016/j.neuroscience.2013.02.055.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
